|
Re: ASN late breaker and CKD sub-study top-line
|
5
|
Resverlogix Corp.
|
Oct 11, 2019 11:23AM
|
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 11, 2019 11:28AM
|
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 11, 2019 11:32AM
|
|
Accelerated approval
|
3
|
Zenith Epigenetics
|
Oct 16, 2019 01:54PM
|
|
Re: Accelerated approval
|
4
|
Zenith Epigenetics
|
Oct 17, 2019 12:43PM
|
|
Re: Accelerated approval
|
3
|
Zenith Epigenetics
|
Oct 17, 2019 12:48PM
|
|
Re: Accelerated approval
|
3
|
Zenith Epigenetics
|
Oct 21, 2019 02:27PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
4
|
Resverlogix Corp.
|
Oct 21, 2019 08:42PM
|
|
Re: Biogen looks to FDA for approval of early Alzheimers drug.
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 11:42AM
|
|
Re: Options
|
1
|
Resverlogix Corp.
|
Oct 23, 2019 12:41PM
|
|
Re: Breaking down the Webcast
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 01:36PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
2
|
Zenith Epigenetics
|
Oct 24, 2019 04:18PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
1
|
Zenith Epigenetics
|
Oct 24, 2019 04:42PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
2
|
Zenith Epigenetics
|
Oct 24, 2019 07:51PM
|
|
Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
7
|
Zenith Epigenetics
|
Oct 25, 2019 11:07AM
|
|
Re: Over 700K traded in Canada today....
|
3
|
Resverlogix Corp.
|
Oct 25, 2019 05:35PM
|
|
Re: Just back from IR,...
|
6
|
Resverlogix Corp.
|
Oct 26, 2019 11:07AM
|
|
Re: Just back from IR,...
|
3
|
Resverlogix Corp.
|
Oct 27, 2019 11:14AM
|
|
Re: Just back from IR,...
|
2
|
Resverlogix Corp.
|
Oct 27, 2019 11:15AM
|
|
Re: I just can’t see the management going
|
3
|
Resverlogix Corp.
|
Oct 29, 2019 02:22PM
|
